Toniolo P, Koenig K L, Pasternack B S, Banerjee S, Rosenberg C, Shore R E, Strax P, Levitz M
Department of Environmental Medicine, New York University Medical Center, New York 10010.
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):47-50.
Estradiol (E2) circulates in the blood in three states: unbound (U-E2), bound to sex-hormone binding globulin (SHBG-E2), and bound to albumin. There is evidence to support the concept that only U-E2 and albumin-bound E2, are bioavailable (i.e., rapidly extracted by tissues). A case-control study nested within a large cohort of women, in which we are examining the effect of estrogens on breast cancer risk, offered the opportunity to assess the reliability of measurements of E2, the percentage of SHBG-E2, and the percentage of U-E2 based on multiple annual serum specimens. Long-term (1-2 year) reliability, as estimated by the intraclass correlation coefficient, was assessed in a subgroup of 71 premenopausal and 77 postmenopausal controls for whom two or three serum specimens were assayed. In postmenopausal women the intraclass correlation coefficient for a single measurement of total E2 was only 0.51. As for the percentage of SHBG-E2, intraclass correlation coefficients were 0.83 and 0.94, and for U-E2, 0.72 and 0.77 in the premenopausal and postmenopausal groups, respectively. These data suggest that, whereas single determinations of total E2 are insufficient to reliably estimate a woman's true mean level, a single measurement of the percentage of SHBG-E2 or U-E2 is adequate to assess bioavailability of E2 in an epidemiological study, irrespective of day of the menstrual cycle.
雌二醇(E2)在血液中以三种状态循环:游离态(U-E2)、与性激素结合球蛋白结合态(SHBG-E2)以及与白蛋白结合态。有证据支持这样的观点,即只有游离态的E2和与白蛋白结合的E2具有生物活性(即能迅速被组织摄取)。在一大群女性中进行的一项巢式病例对照研究,我们在其中研究雌激素对乳腺癌风险的影响,该研究提供了一个机会,可基于多份年度血清样本评估E2测量值、SHBG-E2百分比以及U-E2百分比的可靠性。通过组内相关系数估计的长期(1 - 2年)可靠性,在71名绝经前和77名绝经后对照的亚组中进行了评估,这些对照者检测了两到三份血清样本。在绝经后女性中,单次测量总E2的组内相关系数仅为0.51。至于SHBG-E2的百分比,绝经前和绝经后组的组内相关系数分别为0.83和0.94,而U-E2的组内相关系数分别为0.72和0.77。这些数据表明,虽然单次测定总E2不足以可靠地估计女性的真实平均水平,但在流行病学研究中,单次测量SHBG-E2或U-E2的百分比就足以评估E2的生物活性,而与月经周期的哪一天无关。